 |
|
Computers help chemists fight emerging infections
August 20, 2007BOSTON, Aug. 19, 2007 - Computer analysis of existing drugs may be key to fighting new infectious agents and antibiotic-resistant pathogens like deadly tuberculosis strains and staph 'superbugs.' Researchers in Canada say the use of such "emergency discovery" technology could save time, money and lives during a sudden outbreak or a bioterrorism attack. They reported here today at the 234th national meeting of the American Chemical Society.
Drug 'repurposing' or 'reprofiling' is not new: Pharmaceutical companies have been seeking new uses of old drugs to extend patent protections and whenever new, off-label uses of the drugs are found. But reprofiling to deliberately develop emergency drugs is a new concept, made possible by advances in chemoinformatics, a new field that merges chemistry with computer science, according to study presenter Artem Cherkasov, Ph.D., of the University of British Columbia in Vancouver, Canada.
"In the case of new infectious threats, there might be no time to develop a completely new drug 'from the ground up,' as the corresponding toxicological studies and regulatory investigations will take years to complete properly," says Cherkasov, a chemist with a background in computer-aided drug design and infectious disease. "Finding an already existing, well-studied therapeutic agent that will kill an emerging bug might provide a rapid, 'first line of defense' response option."
Under the new computer-aided system, the researchers plan to first identify vulnerable cellular components of a pathogen using proteomics, or the study of proteins and their interactions. They will enter these key structures into the computer and, using elements of modern 'Artificial Intelligence,' will identify drugs that have the highest potential for activity against the target and for antimicrobial activity, says Cherkasov. Those compounds with the highest 'ranking' can then be quickly tested in the laboratory against the pathogen and eventually used to treat infected individuals, the researcher says.
The new approach is still in development for possible future use during an actual outbreak, Cherkasov notes. However, many non-antibiotic drugs have been shown to have antibiotic-like properties using this technique, he says. For example, computer studies have suggested that lovastatin, a drug marketed to lower cholesterol, and gentisic acid, an anti-inflammatory drug related to aspirin, both show promise as strong antibiotics. But more studies are needed before these compounds can be recommended for use as antibiotics in a clinical setting, he adds.
"It is not totally unexpected as there are thousands of existing drugs that are already enriched with target-binding structural features," Cherkasov says. "Many of them were not designed as antibiotics but have the potential to act as such."
"The chemical structures of compounds we identify usually look nothing like known antibiotics. But if a compound behaves like antibiotic in a computational model, it may act as one in a real life," says Cherkasov, who has programmed his computer system to identify 'antibiotic likeness,' or those chemical structures which have the most potential for antibiotic activity.
There is a growing need to expand and complement the range of available antimicrobial compounds, as many big pharmaceutical companies have withdrawn from the field of anti-infective agents, according to Cherkasov. Only two novel antibiotics have entered the market in the last 20 years, he says.
The researchers plan to soon begin testing some of the newly identified antibiotic candidates against methicillin-resistant Staphylococcus aureus (MRSA). Also known as 'superbugs,' these bacteria are an increasingly worrisome cause of serious hospital-based infections and infections acquired in community settings.
Although Cherkasov's research team specializes in battling bacterial infections, similar techniques can be applied to emerging viral infections, such as SARS and bird flu, he says. Likewise, the technique also provides a potential means of identifying quick treatments for bioterrorism agents, such as new strains of anthrax, as well as rare infectious diseases such as those sometimes encountered in third-world countries.
American Chemical Society
Under the new computer-aided system, the researchers plan to first identify vulnerable cellular components of a pathogen using proteomics, or the study of proteins and their interactions. They will enter these key structures into the computer and, using elements of modern 'Artificial Intelligence,' will identify drugs that have the highest potential for activity against the target and for antimicrobial activity, says Cherkasov. Those compounds with the highest 'ranking' can then be quickly tested in the laboratory against the pathogen and eventually used to treat infected individuals, the researcher says.
The new approach is still in development for possible future use during an actual outbreak, Cherkasov notes. However, many non-antibiotic drugs have been shown to have antibiotic-like properties using this technique, he says. For example, computer studies have suggested that lovastatin, a drug marketed to lower cholesterol, and gentisic acid, an anti-inflammatory drug related to aspirin, both show promise as strong antibiotics. But more studies are needed before these compounds can be recommended for use as antibiotics in a clinical setting, he adds.
"It is not totally unexpected as there are thousands of existing drugs that are already enriched with target-binding structural features," Cherkasov says. "Many of them were not designed as antibiotics but have the potential to act as such."
"The chemical structures of compounds we identify usually look nothing like known antibiotics. But if a compound behaves like antibiotic in a computational model, it may act as one in a real life," says Cherkasov, who has programmed his computer system to identify 'antibiotic likeness,' or those chemical structures which have the most potential for antibiotic activity.
There is a growing need to expand and complement the range of available antimicrobial compounds, as many big pharmaceutical companies have withdrawn from the field of anti-infective agents, according to Cherkasov. Only two novel antibiotics have entered the market in the last 20 years, he says.
The researchers plan to soon begin testing some of the newly identified antibiotic candidates against methicillin-resistant Staphylococcus aureus (MRSA). Also known as 'superbugs,' these bacteria are an increasingly worrisome cause of serious hospital-based infections and infections acquired in community settings.
Although Cherkasov's research team specializes in battling bacterial infections, similar techniques can be applied to emerging viral infections, such as SARS and bird flu, he says. Likewise, the technique also provides a potential means of identifying quick treatments for bioterrorism agents, such as new strains of anthrax, as well as rare infectious diseases such as those sometimes encountered in third-world countries.
American Chemical Society
Rethinking Who Should Be Considered 'Essential' During a Pandemic Flu Outbreak
Not only are doctors, nurses, and firefighters essential during a severe pandemic influenza outbreak. So, too, are truck drivers, communications personnel, and utility workers.
Progress in infectious disease surveillance but gaps remain, says Mailman School of Public Health
The key to control any pandemic is early identification and rapid response. Although considerable progress has been made in global infectious disease surveillance, few scientists are optimistic that an effective early warning system is in place, and many gaps remain.
Novel plague virulence factor identified
Researchers at Duke University Medical Center have identified a previously unknown family of virulence factors that make the bacterium responsible for the plague especially efficient at killing its host.
Lyme disease prevention program launched in Connecticut
Researchers at the Emerging Infections Program (EIP) at Yale School of Medicine in partnership with the Connecticut Department of Public Health and the Centers for Disease Control and Prevention have launched a Lyme disease prevention study in 21 Connecticut communities.
Returning travellers could highlight emerging infections worldwide
Though picking up a Salmonella infection abroad could ruin your holiday, reporting it to your doctor could help detect emerging infections in tourist destinations, according to an article published today in BMC Medicine. A comprehensive database containing details of the infections that travellers pick up could help inform countries that have limited surveillance systems about possible disease outbreaks.
More Emerging Infections Current Events and Emerging Infections News Articles
 | Emerging Infections (Scheld, Emerging Infections) The twenty chapters in this volume provide concise and timely updates on the epidemiology, clinical features, and prevention and control strategies for a number of important emerging and re-emerging infectious diseases and syndromes. They highlight the importance of disease surveillance and timely response as the best way to ensure that these diseases do not cause severe morbidity and mortality... |
 | Emerging Infections (Biomedical Research Reports) Emerging Infections is a reprint of the inaugural volume of the thematic serial, Biomedical Research Reports Series that provides annual updates on hot topics of interest to a broad spectrum of the biomedical research community. This volume provides state-of-the-art reviews of the most important "new" and reemerging bacterial, viral, and parasitic infections, their life cycles, host defense... |
 | Emerging Infections 3 |
 | Networked Disease: Emerging Infections in the Global City (Studies in Urban and Social Change) A collection of writings by leading experts and newer researchers on the SARS outbreak and its relation to infectious disease management in progressively global and urban societies.Presents original contributions by scholars from seven countries on four continents Connects newer thinking on global cities, networks, and governance in a post-national era of public health regulations and... |
 | Beyond Antibiotics: Strategies for Living in a World of Emerging Infections and Antibiotic-Resistant Bacteria by Michael A. Phd Schmidt At a time when the numbers of emerging infections and antibiotic-resistant bacteria are rising sharply, the supply of new antibiotic drugs has been steadily decreasing. In addition, many health providers have failed to consider that our bodies are cloaked in a blanket of bacteria so pervasive that the bacterial cells outnumber our “human” cells by a factor of ten. In short, we are living in a... |
 | Pathology Of Emerging Infections (Pathology of Emerging Infections) |
 | Infection Control and Emerging Infectious Diseases by William B. Inman Delirium is a medical emergency and it s underlying cause must be identified and treated immediately. If the cause is not identified the repercussions can be potentially deadly. At the very least, complications increase morbidity, the risk for long-term placement and healthcare costs. This book is intended to educate the healthcare professional on the early recognition of delirium, lending itself... |
 | Emerging Neurological Infections (Neurological Disease and Therapy) Offering a clear and authoritative overview of recent developments in microbiology and neuroscience, this reference describes factors contributing to the emergence and resurgence of neurological infections-studying both new and drug-resistant pathogens, as well as long-term prevention and control strategies for these... |
 | New and Evolving Infections of the 21st Century (Emerging Infectious Diseases of the 21st Century) The past decade has been highlighted by numerous advances in research of medical scientific knowledge, medical technology and the biological and diagnostic techniques-but somewhat less dramatic changes or improvement in management of medical conditions. This volume in the Emerging Infectious Disease of the 21st century series, addresses some of the emerging issues and controversies in Infectious... |
 | Infections and the Cardiovascular System: New Perspectives (Emerging Infectious Diseases of the 21st Century) by I.W. Fong Infectious agents have been recognized to involve the heart and vascular system for well over a century. Traditional concepts and teachings of their involvement in the pathogenesis of disease have been by a few established mechanisms. Since the last decade of the 20th century there has been renewed interest in the medical and public media on infectious diseases affecting the cardiovascular and... |
| © 2008 BrightSurf.com |